Fetal/Infant Origins of Adult Vascular Disease-Reference-Cited by-同舟云学术

Fetal/Infant Origins of Adult Vascular Disease

Published:2020-06-04 Issue:4 Volume:18 Page:418-420
ISSN:1570-1611
Container-title:Current Vascular Pharmacology
language:en
Short-container-title:CVP

Author:

Paraskevas Kosmas I.¹,Briana Despina D.²,Malamitsi-Puchner Ariadne²,Mikhailidis Dimitri P.³

Affiliation:

1. Department of General and Vascular Surgery, Central Clinic of Athens, Athens, Greece

2. Medical School, National and Kapodistrian University of Athens, Athens, Greece

3. Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London, London, United Kingdom

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference19 articles.

1. Barker D.J.; The fetal and infant origins of adult disease. BMJ 1990,301(6761),1111

2. Barker D.J.; The intrauterine origins of cardiovascular and obstructive lung disease in adult life. The Marc Daniels Lecture 1990. J R Coll Physicians Lond 1991,25(2),129-133

3. Barker D.J.; Fetal origins of coronary heart disease. Br Heart J 1993,69(3),195-196

4. Barker D.J.; Winter P.D.; Osmond C.; Margetts B.; Simmonds S.J.; Weight in infancy and death from ischaemic heart disease. Lancet 1989,2(8663),577-580

5. Guerri-Guttenberg R.; Castilla R.; Cao G.; Azzato F.; Ambrosio G.; Milei J.; Coronary intimal thickening begins in fetuses and progresses in pediatric population and adolescents to atherosclerosis. Angiology 2020,71(1),62-69

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aortic Intima-Media Thickness is Increased in Neonates of Mothers with Gestational Diabetes Mellitus: The Role of Thioredoxin-Interacting Protein as a Marker of Oxidative Stress;Current Vascular Pharmacology;2023-07

2. Aortic Intima-Media Thickness in Neonates of Mothers with Gestational Diabetes Mellitus: An Opportunity for Early Initiation of Vascular Disease Prevention;Current Vascular Pharmacology;2023-07

3. Effect of Gestational Diabetes Mellitus and Hypercholesterolemia on Fetal Cardiovascular Disease Risk: The Role of Epigenetics;Current Vascular Pharmacology;2022-07